Mind Medicine (MindMed) Inc. (MMED.NE)
Chart Events
Performance Outlook
| Previous Close | 0.7900 |
| Open | 0.7700 |
| Bid | 0.8400 x N/A |
| Ask | 0.8600 x N/A |
| Day's Range | 0.7700 - 0.9000 |
| 52 Week Range | 0.6200 - 4.5900 |
| Volume | |
| Avg. Volume | 297,555 |
| Market Cap | 359.082M |
| Beta (5Y Monthly) | 1.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3030 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for MMED.NE
Related Research
- CNW Group
MindMed Announces Completion of Share Redesignation
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) ("MindMed'' or the "Company") announces that it has completed its previously announced redesignation of its subordinate voting shares as common shares (the "Common Shares") of the Company. The Common Shares will be assigned CUSIP number 60255C802 and ISIN number CA60255C8025 following the redesignation. The Common Shares will begin trading on a post-Redesignation basis under the new CUSIP and ISIN numbers on the NEO Exchange and NASDAQ at m
- PR Newswire
Mindmed Announces Voting Results for Annual General and Special Meeting
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), announces the voting results of the Company's annual general and special meeting of shareholders held on June 1, 2022 (the "Meeting").
- CNW Group
MindMed to Participate in the Jefferies Global Healthcare Conference
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that Robert Barrow, Chief Executive Officer and Director, will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY from June 8-10, 2022.
